49 Citations (Scopus)

Abstract

Many researches have been trying to find the potential biomarkers for Alzheimer's disease (AD). We hereby used the proteomics method to search for protein expression differences in the serum between AD patients and controls. We enrolled 59 AD patients and 74 age- and sex-matched controls in this study. Ten AD patients and 10 controls were selected for proteomic analysis. Apolipoprotein A-I (ApoA-I) was found to have a lower expression in the AD group by a proteomics two-dimensional gel electrophoresis study. We further measured the serum ApoA-I level which was significantly lower in the AD patients (112.29 ± 21.33 mg/dl) in comparison to the controls (144.53 ± 19.91 mg/dl; p <0.0002). Lower serum ApoA-I levels might be a potential biomarker for AD.

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalDementia and Geriatric Cognitive Disorders
Volume21
Issue number3
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Apolipoprotein A-I
Proteomics
Alzheimer Disease
Biomarkers
Serum
Electrophoresis, Gel, Two-Dimensional
Research
Proteins

Keywords

  • Alzheimer's disease
  • Apolipoprotein A-I (ApoA-I)
  • Polymorphism
  • Proteomics

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Geriatrics and Gerontology

Cite this

Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease. / Liu, Hsing Cheng; Hu, Chaur Jong; Chang, Jan Gowth; Sung, Shing Ming; Lee, Long Shyong; Yuan, Rey Yue; Leu, Sy Jye.

In: Dementia and Geriatric Cognitive Disorders, Vol. 21, No. 3, 02.2006, p. 155-161.

Research output: Contribution to journalArticle

Liu, Hsing Cheng ; Hu, Chaur Jong ; Chang, Jan Gowth ; Sung, Shing Ming ; Lee, Long Shyong ; Yuan, Rey Yue ; Leu, Sy Jye. / Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease. In: Dementia and Geriatric Cognitive Disorders. 2006 ; Vol. 21, No. 3. pp. 155-161.
@article{62d339dd83cc40b0a761909f8ba4c186,
title = "Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease",
abstract = "Many researches have been trying to find the potential biomarkers for Alzheimer's disease (AD). We hereby used the proteomics method to search for protein expression differences in the serum between AD patients and controls. We enrolled 59 AD patients and 74 age- and sex-matched controls in this study. Ten AD patients and 10 controls were selected for proteomic analysis. Apolipoprotein A-I (ApoA-I) was found to have a lower expression in the AD group by a proteomics two-dimensional gel electrophoresis study. We further measured the serum ApoA-I level which was significantly lower in the AD patients (112.29 ± 21.33 mg/dl) in comparison to the controls (144.53 ± 19.91 mg/dl; p <0.0002). Lower serum ApoA-I levels might be a potential biomarker for AD.",
keywords = "Alzheimer's disease, Apolipoprotein A-I (ApoA-I), Polymorphism, Proteomics",
author = "Liu, {Hsing Cheng} and Hu, {Chaur Jong} and Chang, {Jan Gowth} and Sung, {Shing Ming} and Lee, {Long Shyong} and Yuan, {Rey Yue} and Leu, {Sy Jye}",
year = "2006",
month = "2",
doi = "10.1159/000090676",
language = "English",
volume = "21",
pages = "155--161",
journal = "Dementia and Geriatric Cognitive Disorders",
issn = "1420-8008",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease

AU - Liu, Hsing Cheng

AU - Hu, Chaur Jong

AU - Chang, Jan Gowth

AU - Sung, Shing Ming

AU - Lee, Long Shyong

AU - Yuan, Rey Yue

AU - Leu, Sy Jye

PY - 2006/2

Y1 - 2006/2

N2 - Many researches have been trying to find the potential biomarkers for Alzheimer's disease (AD). We hereby used the proteomics method to search for protein expression differences in the serum between AD patients and controls. We enrolled 59 AD patients and 74 age- and sex-matched controls in this study. Ten AD patients and 10 controls were selected for proteomic analysis. Apolipoprotein A-I (ApoA-I) was found to have a lower expression in the AD group by a proteomics two-dimensional gel electrophoresis study. We further measured the serum ApoA-I level which was significantly lower in the AD patients (112.29 ± 21.33 mg/dl) in comparison to the controls (144.53 ± 19.91 mg/dl; p <0.0002). Lower serum ApoA-I levels might be a potential biomarker for AD.

AB - Many researches have been trying to find the potential biomarkers for Alzheimer's disease (AD). We hereby used the proteomics method to search for protein expression differences in the serum between AD patients and controls. We enrolled 59 AD patients and 74 age- and sex-matched controls in this study. Ten AD patients and 10 controls were selected for proteomic analysis. Apolipoprotein A-I (ApoA-I) was found to have a lower expression in the AD group by a proteomics two-dimensional gel electrophoresis study. We further measured the serum ApoA-I level which was significantly lower in the AD patients (112.29 ± 21.33 mg/dl) in comparison to the controls (144.53 ± 19.91 mg/dl; p <0.0002). Lower serum ApoA-I levels might be a potential biomarker for AD.

KW - Alzheimer's disease

KW - Apolipoprotein A-I (ApoA-I)

KW - Polymorphism

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=32044446447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044446447&partnerID=8YFLogxK

U2 - 10.1159/000090676

DO - 10.1159/000090676

M3 - Article

C2 - 16391478

AN - SCOPUS:32044446447

VL - 21

SP - 155

EP - 161

JO - Dementia and Geriatric Cognitive Disorders

JF - Dementia and Geriatric Cognitive Disorders

SN - 1420-8008

IS - 3

ER -